Terminated PHASE4 INTERVENTIONAL 2-arm NCT00289055

The Study to Compare the Treatment of Angioplasty and Stents in SFA Occlusions. (DURAVEST)

A Clinical Investigation of the SMART™ Nitinol Self-Expandable Stent Versus Balloon Angioplasty for the Treatment of Superficial Femoral Artery Occlusions

Sponsor: Cordis US Corp.

Conditions Arterial Occlusive Diseases

Interventions angioplasty stent

Updated 7 times since 2017 Last updated: Feb 20, 2009 Started: Nov 30, 2005 Primary completion: Jun 30, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

lack of enrollment

Other terminated trials from Cordis US Corp.

More terminations from Cordis US Corp.

Listed as NCT00289055, this PHASE4 trial focuses on Arterial Occlusive Diseases and remains terminated or withdrawn. Sponsored by Cordis US Corp., it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Dec 2025 — Present [monthly]

Terminated PHASE4
Sep 2024 — Dec 2025 [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cordis US Corp.

Data source: Cordis US Corp.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Amsterdam, Netherlands